IP Strategies for German Bio and AI Companies: Building Strategic Intellectual Property Portfolios in Korea
We are pleased to invite you to an insightful seminar on "IP Strategies for German Bio and AI Companies," where we will explore the essential steps to building a robust and tailored IP portfolio in Korea. This seminar will focus on key strategies for German bio and AI companies, with real-world examples from our clients, Three Billion and Aetech.
Key Highlights:
- Practical strategies for German bio and AI companies to build impactful, market-ready IP portfolios customized for the Korean market.
- Bespoke IP portfolio development approaches aligned with each company's technological strengths and patent acquisition goals.
- Comprehensive competitive and industry analysis to guide strategic IP decision-making.
- Case Studies in Focus:
- Three Billion – Excelling in medical AI diagnostics: Their success in technology-based IPO and navigating Korea’s IP landscape.
- Aetech – Innovating AI robotics for waste management: Winning the WIPO Award and establishing a strong IP foundation in Korea.
Seminar info:
- Date: January 14, 2025, 10 AM (registration from 9:30)
- Location: KGCCI (1Fl., room Berlin)
41-7, Jahamun-ro 24-gil, Jongno-gu, Seoul 03042
- Speaker: Mr. Sangyeol Lee, Representative Patent Attorney
This session is highly beneficial for companies looking to expand their operations into Korea and optimize their intellectual property strategies to protect innovation in a highly competitive market. The KGCCI M2M seminar is exclusive to members.
If you have any question, please contact KGCCI Membership Team 02-3780-4631 or members@kgcci.com
We look forward to welcoming you!
Sincerely,
KGCCI Membership Team